The Norwegian Institute of Public Health
Our goal is to improve public health through promotion of good health and prevention of disease. The Norwegian Institute of Public Health is a national centre of excellence in the areas of epidemiology, mental health, control of infectious diseases, environmental medicine, forensic toxicology and drug abuse. Our vision: A healthier society. Our motto: Knowledge for better public health.
Norwegian Prescription Database celebrates 5 years
Consumption of stimulant drugs used for ADHD has risen significantly in recent years. Last year nearly 14 000 children were treated. 75 % were boys. The five year old Norwegian Prescription Database at the Norwegian Institute of Public Health allows us to follow drug use in different group and to comment on trends in use over the last 5 years.
Read more [23.04.2009]
NOS-M seminar
The seminar is intended to highlight cutting-edge approaches to understanding the development and prevention of metabolic and nutritional disorders with special emphasis on type 2 diabetes and obesity. It will be held in Oslo from August 26th to August 28th 2009 and will be financed by the Joint Committee of the Nordic Medical Research Councils (NOS-M). NOS-M seminars are intended for both young and senior researchers, giving PhD students an opportunity to interact with senior scientists. The seminar is primarily open to participants from all Nordic countries.
Read more [17.04.2009]
E.coli-bacteria were not found in the 22 samples taken from food and water in Malvik in connection with the recent outbreak of
E.coli O157. The National Veterinary Institute has now completed the tests on behalf of the Norwegian Food Safety Authority. The Norwegian Institute of Public Health has completed the testing of other members of the three families that are affected by the outbreak. Two people who did not become ill were shown to have
E.coli O157-bacteria in their intestines.
Read more [07.04.2009]
New study
Diabetic drivers who use insulin have a slightly increased risk of being involved in road traffic accidents. Users of medicines for certain digestive problems have a similar increased risk. Users of blood glucose-lowering tablets do not have an increased risk. This is shown in a new study from the Norwegian Institute of Public Health.
Read more [03.04.2009]
Background
In the first three months of 2009, the Norwegian Institute of Public Health has registered four cases of hemolytic uremic syndrome (HUS) among children as a result of infection with sorbitol-fermenting E. coli O157:H-. Researchers from the Norwegian Institute of Public Health and the National Veterinary Institute have summarised their knowledge about this E.coli variant.
More [02.04.2009]
Mothers with many negative thoughts and feelings are more likely to give their children unhealthy food. This is shown in a study from the Norwegian Institute of Public Health (NIPH) in collaboration with the University of Oslo.
Les mer [01.04.2009]
The Norwegian Institute of Public Health has confirmed the same DNA strain of the bacterium
E.coli O157 (EHEC) among the three children with hemolytic uremic syndrome (HUS) that have been reported this year. The first child became ill in January, the second in February and the third in March. In addition, a sibling of one of the children has also developed HUS, but it has not yet been confirmed whether this is the same bacterial strain. As the patients are from three different counties in Norway, the Norwegian Institute of Public Health is now handling these cases as a national disease outbreak.
Read more [27.03.2009]
A new study from the Norwegian Institute of Public Health shows a positive link between the amount of the hypnotic (sleeping medicine) zopiclone in the blood and the chance of being assessed as impaired in a clinical examination. The study also included drivers who only showed alcohol in their blood test.
Read more [26.03.2009]
The risk of being involved in a traffic accident with personal injury is significantly higher among codeine users than non-users. However, sporadic or moderate use of codeine alone does not carry an increased risk, according to a newly published study from the Norwegian Institute of Public Health.
Read more [24.03.2009]
Chronic human papilloma virus (HPV)-infections can lead to cellular changes in the cervix that can be a pre-stage to cervical cancer. Surgical treatment of these pre-stages gives an increased risk of preterm birth in subsequent pregnancies. As the HPV-vaccine can prevent pre-stages of cervical cancer, it may therefore reduce the number of preterm births. A new Norwegian study has calculated the benefits of HPV-vaccination.
Read more [17.03.2009]
